Magnus Edner
Overview
Explore the profile of Magnus Edner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
1136
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ugarph-Morawski A, Wandell P, Benson L, Savarese G, Lund L, Dahlstrom U, et al.
Arch Gerontol Geriatr
. 2024 Oct;
129:105645.
PMID: 39368269
Background: Many patients with heart failure (HF) are managed in primary care, and comorbidities are common. Anemia is one frequent comorbidity. The aim of this study was to assess the...
2.
Lindberg F, Lund L, Benson L, Schrage B, Edner M, Dahlstrom U, et al.
ESC Heart Fail
. 2022 Feb;
9(2):822-833.
PMID: 35170237
Aims: Factors influencing follow-up referral decisions and their prognostic implications are poorly investigated in patients with heart failure (HF) with reduced (HFrEF), mildly reduced (HFmrEF), and preserved (HFpEF) ejection fraction...
3.
Basic C, Rosengren A, Alehagen U, Dahlstrom U, Edner M, Fu M, et al.
Eur J Heart Fail
. 2020 Jul;
22(7):1125-1132.
PMID: 32613768
Aims: The prevalence and hospitalizations of patients with heart failure (HF) aged <55 years have increased in Sweden during the last decades. We aimed to compare characteristics of younger and...
4.
Savarese G, Jonsson A, Hallberg A, Dahlstrom U, Edner M, Lund L
Int J Cardiol
. 2020 Jan;
307:194.
PMID: 31973886
No abstract available.
5.
Eriksson B, Wandell P, Dahlstrom U, Nasman P, Lund L, Edner M
Scand J Prim Health Care
. 2019 Nov;
37(4):434-443.
PMID: 31724475
The prognostic value of natriuretic peptides in the management of heart failure (HF) patients with ejection fraction (EF) <40% is well established, but is less known for those with EF...
6.
Savarese G, Jonsson A, Hallberg A, Dahlstrom U, Edner M, Lund L
Int J Cardiol
. 2019 Sep;
298:59-65.
PMID: 31521440
Background: The role of anemia in heart failure with mid-range and preserved ejection fraction (HFmrEF, EF 40-49% and HFpEF, EF ≥50%) is unknown. We aimed to compare prevalence of, associations...
7.
Johansson I, Dahlstrom U, Edner M, Nasman P, Ryden L, Norhammar A
Diab Vasc Dis Res
. 2018 Sep;
15(6):494-503.
PMID: 30176743
Objective: To study the characteristics and prognostic implications of type 2 diabetes in different heart failure entities from a nationwide perspective. Methods: This observational study comprised 30,696 heart failure patients...
8.
Savarese G, Vasko P, Jonsson A, Edner M, Dahlstrom U, Lund L
Ups J Med Sci
. 2018 Aug;
124(1):65-69.
PMID: 30092697
Heart failure (HF) represents a global pandemic. Although in HF with reduced ejection fraction (HFrEF) randomized controlled trials have provided effective treatments, prognosis still remains poor, with signals of undertreatment....
9.
Paren P, Dahlstrom U, Edner M, Lappas G, Rosengren A, Schaufelberger M
Int J Cardiol
. 2018 Mar;
257:118-124.
PMID: 29506681
Aims: Diuretics are recommended for treating congestive symptoms in heart failure (HF). The short- and long-term prognostic effects of diuretic treatment at hospital discharge have not been studied in randomized...
10.
Lofsjogard J, Kahan T, Diez J, Lopez B, Gonzalez A, Ravassa S, et al.
Am J Cardiol
. 2017 May;
119(12):2042-2048.
PMID: 28464988
Disturbances of collagen metabolism may alter the myocardial collagen network and contribute to cardiac remodeling and prognosis in heart failure (HF). Collagen type I synthesis and degradation can be assessed...